skip to content
Primary navigation

Glucagon

Drug - Glucagon Kit (glucagon for injection) [various manufacturers]

Baqsimi™ (glucagon powder) [Eli Lilly and Company]

Gvoke™ Hypopen (glucagon injection) [Xeris Pharmaceuticals, Inc.]

Gvoke™ Pre-Filled Syringe (glucagon injection) [Xeris Pharmaceuticals, Inc.]

February 2020

Therapeutic area - Glucagon Agents

Approval criteria for Glucagon Kit

  • No prior authorization is required
  • Quantity limits apply

Approval criteria for Baqsimi

  • Patient must be at least 4 years old AND
  • Patient has a diagnosis of type 1 or type 2 diabetes AND
  • Patient must NOT have pheochromocytoma, an insulinoma, or known hypersensitivity to glucagon or any of the excipients in the product AND
  • Prescriber provides documentation to substantiate ALL the following:
    • Patient and/or caregiver has been trained to recognize the signs and symptoms of hypoglycemia and has a plan of action to reverse hypoglycemia when it occurs AND
    • Patient has been instructed on how to use Baqsimi and how to discard and replace used or unused Baqsimi AND
    • Patient has a comprehensive diabetes care plan including self-monitoring of blood glucose or continuous glucose monitoring

Approval criteria for Gvoke

  • Patient must be at least 2 years old AND
  • Patient has a diagnosis of type 1 or type 2 diabetes AND
  • Patient must NOT have pheochromocytoma, an insulinoma, or known hypersensitivity to glucagon or any of the excipients in the product AND
  • Prescriber provides documentation to substantiate ALL the following:
    • Patient and/or caregiver has been trained to recognize the signs and symptoms of hypoglycemia and has a plan of action to reverse hypoglycemia when it occurs AND
    • Patient and/or caregiver has been instructed on how to use Gvoke and how to discard and replace used or unused Gvoke AND
    • Patient has a comprehensive diabetes care plan including self-monitoring of blood glucose or continuous glucose monitoring

Quantity limits

  • Glucagon Kit: 2 kits per 34 days
  • Baqsimi: 2 devices per 34 days
  • Gvoke: 2 autoinjectors or 2 prefilled syringes per 34 days

Questions?

MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top